poisar

Stock

Whitehawk Therapeutics, Inc. WHWK

$4.87+0.83%

Overview

WHWK market data

Price History

WHWK price chart · 1M
O
4.90
H
4.97
L
4.87
C
4.87
Vol
61,741.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$4.90
Previous Close
$4.83
Day High
$4.97
Day Low
$4.87
52 Week High
$5.48
52 Week Low
$3.41
7 Day Return
+1.04%
30 Day Return
+32.52%
90 Day Return
+3.18%
1 Year Return
+20.84%
Daily Notional Volume
$300.7K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.44
Diluted earnings per share over the trailing twelve months.
Beta
0.95
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
99.4%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.70 – $5.50
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $253.3M · P/B 0.84 · P/S 9.12.

Company News

5 captured
8-K filing — Whitehawk Therapeutics, Inc. (WHWK)SEC EDGAR · Aug 6, 2026, 2:08 PM
Whitehawk Therapeutics Q2 EPS $(0.20) Beats $(0.30) EstimateBenzinga · Aug 6, 2026, 12:46 PM
Leerink Partners Initiates Coverage On Whitehawk Therapeutics with Outperform Rating, Announces Price Target of $9Benzinga · Jul 13, 2026, 5:55 PM
Whitehawk Therapeutics Collaborates With Biocytogen To Develop Bispecific Antibody-Drug ConjugatesBenzinga · Jul 7, 2026, 12:10 PM
Whitehawk Therapeutics Files Prospectus For Resale Of 22,321,887 Shares Of Common StockBenzinga · May 29, 2026, 8:25 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock